PSCA-AVL9 Fusion FISH Probe
The PSCA-AVL9 Fusion FISH Probe is used to confirm a fusion of the PSCA and AVL9 genes. The fusion of the PSCA and AVL9 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PSCA-AVL9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PSCA-AVL9-20-AQAQ | 20 (40 μL) | 200 μL |
|
PSCA Gene Summary
This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. This gene includes a polymorphism that results in an upstream start codon in some individuals; this polymorphism is thought to be associated with a risk for certain gastric and bladder cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Gene Name: Prostate Stem Cell Antigen
Chromosome: CHR8: 143751725 -143764145
Locus: 8q24.3
AVL9 Gene Summary
The AVL9 Cell Migration Associated (AVL9) gene is located on chr7 :32535175-32623779 at 7p14.3.
Gene Name: AVL9 Cell Migration Associated
Chromosome: CHR7: 32535175 -32623779
Locus: 7p14.3
Gene Diseases
The PSCA AVL9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|